Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
Pediatric Studies Characteristics - Detail
FDA Home
Pediatrics
Pediatric Studies Characteristics
Detail
-
Please note:
JavaScript must be enabled for this application to work properly.
Check your settings
if you are unsure if your JavaScript is enabled.
Approval Date:
02/17/2011
Trade Name:
Hizentra
Generic or Proper Name (*):
Globulin Subcutaneous (Human), 20% Liquid *
Indications Studied:
Postmarketing study
Therapeutic Category:
Immune Serum
Ages Studied:
2 - < 18 years
Study #:
1
Study Type:
Efficacy/Safety/Pharmacokinetic/Tolerability
Study Design:
Multicenter, Open-label, Single arm
No Patients:
51
No Centers:
15
No Countries:
8
BPCA(B), PREA(P):
P
Unknown:
0
-
-